IGM Biosciences price target lowered to $45 from $58 at H.C. Wainwright

H.C. Wainwright analyst Robert Burns lowered the firm’s price target on IGM Biosciences to $45 from $58 and keeps a Buy rating on the shares post the Q3 results.